Medicare regulators are proceeding with a plan to stop healthcare providers from contracting third-party companies for remote patient monitoring. Although widespread opposition from tech vendors, insurers, and medical groups failed to cancel the rule, officials agreed to push back the ban to 2029 to let organizations establish in-house capabilities. Industry advocates intend to use this delay to lobby for alternate approaches, including value-based payment models and restructured regulatory guardrails.
Key points
Healthcare providers have received a two-year extension to transition their remote monito…: Healthcare providers have received a two-year extension to transition their remote monitoring operations entirely in-house.
Industry groups plan to spend the delay lobbying policymakers to establish alternative va…: Industry groups plan to spend the delay lobbying policymakers to establish alternative value-based payment pathways.
Despite broad industry pushback, federal regulators remain committed to eliminating outsi…: Despite broad industry pushback, federal regulators remain committed to eliminating outside remote monitoring vendors.
Sources checked by our analysis pipeline: 1
Medicare regulators this week pushed forward with a controversial plan to ban hospitals and other providers from using third parties to deliver remote patient monitoring services, despite overwhelming opposition from health tech companies, hospitals, insurers, and specialty organizations.
But regulators also offered providers a reprieve in the form of a two-year delay in implementation that’s aimed at allowing time for providers to build in-house services. Advocates representing vendors, hospitals, and other stakeholders see that window as an opportunity to push for another plan.
“The story is that we have two years to come up with something better,” said Christopher Adamec, a lobbyist who advises the Remote Monitoring Leadership Council, a group of leading vendors. “My mission here is to find and move forward a value-based payment pathway or some set of guardrails, or some alternative to this.”
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Medical researchers are examining how discovering early biological markers of neurological conditions reshapes a person's daily life before physical symptoms even emerge. Patients learning of elevated amyloid levels frequently reassess normal forgetfulness, modify long-term plans, and face shifting relationships with colleagues and relatives. This psychological transformation reflects a broader clinical trend toward diagnosing and treating risk factors long before tangible impairments manifest.
Public health officials are facing growing regulatory and medical challenges as concentrated supplements derived from the Southeast Asian plant proliferate across convenience stores. Because these potent extracts interact with human opioid receptors, policymakers are weighing federal and local bans to curb emerging safety risks. However, extensive consumer unfamiliarity and intense industry lobbying continue to complicate nationwide oversight efforts.
National healthtech agency Synapxe is taking the billing platforms offline across major public medical facilities to fortify back-end systems and digital infrastructure. While physical counters and kiosks cannot process transactions during this upgrade window, medical care and clinical operations will run without interruption. Patients are being directed to digital channels or external payment kiosks until the platforms resume normal operations on November 9.